The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are constantly updated:

Vaccines and therapeutics in development

Diagnostics with U.S. FDA emergency use authorization

Clinical trials of biopharma products affected by COVID-19

The COVID-19 pandemic’s impact on inspections of drug and device manufacturing sites is a matter of record, but the agency says it is on track to resume inspections for high-risk considerations. However, the FDA also said it will likely make more extensive use of virtual inspection tools going forward, a development that may ease some of the operational interruptions engendered by conventional on-site inspections.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beigene, Biontech, Chemocentryx, Eisai, Glaxosmithkline, Merck, Pfizer, Vir.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acasti, Anixa, Antibe, Bavarian Nordic, Cantargia, Crispr, Cyxone, Defence, Galapagos, Grace, HTL, HS, Ibio, Inozyme, Kempharm, Molgenie, Nabriva, Nexturn, Nkarta, Oncology Pharma, Ontochem, Regen, Roivant, Rosvivo, Sinovant, Sumitomo, Wuxi, Xcelerate.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Everest, Lyndra, Merck & Co., RDIF.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcellera, Achilles, Aeterna, Angios, Applied DNA, Aptorum, Asieris, Beigene, BMS, CSL, Darwinhealth, Enesi, Evvivax, Fusion, Generex, Inspira Pharma, Insud, ITM, Jasper, Lexaria, Merck & Co., Mimedx, Moderna, Molecular Partners, Neuropathix, Nova Mentis, Novavax, Ocugen, Sanofi, Seven Bridges, Springworks, Trevena, Uniqure, Vectura, Yiling, Youfeng, ZS.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelrx, AGTC, Altavant, Arcutis, Cytokinetics, Follicum, Hepion, Horizon, Humanigen, Isofol, Moderna, Moonlake, Nervgen, Novavax, Peptomyc, Revelation, Stealth, Surface Ophthalmics, Tetra, Zynerba.